Advertisement
Home »

Bimekizumab Exhibits Lasting Efficacy for Patients With Psoriasis

Apr 01, 2024

REFERENCES & ADDITIONAL READING

Lebwohl M, et al. Bimekizumab efficacy from treatment initiation through 4 years in patients with plaque psoriasis: A comprehensive, long-term, pooled analysis from BE BRIGHT. Presented at: AAD 2024 Annual Meeting, 8–12 March 8-12, 2024, San Diego, CA.

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


EXPLORE MORE

Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

RELEVANT ARTICLES FOR YOU

Advertisement